- Corporate Officers - B
- Bybee Clinton
Insider Trading History of Bybee Clinton
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bybee Clinton since 2012.
This trader's CIK number is 1219043.
At the time of last reporting, Bybee Clinton was the 10% Owner of Neumora Therapeutics, Inc.. (stock ticker symbol NMRA).
Also see all insider trading activities at Neumora Therapeutics, Inc..
Note that in the past
BYBEE CLINTON also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Neumora Therapeutics, Inc. (NMRA) by Bybee Clinton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | NMRA | 1,500,000 | $25,500,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Fate Therapeutics Inc (FATE) by Bybee Clinton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | FATE | 833,333 | $4,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Syros Pharmaceuticals, Inc. (SYRS) by Bybee Clinton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | SYRS | 400,000 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Karuna Therapeutics, Inc. (KRTX) by Bybee Clinton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | KRTX | 200,000 | $3,200,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Xtera Communications, Inc. (XCOM) by Bybee Clinton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | XCOM | 600,000 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kythera Biopharmaceuticals Inc (KYTH) by Bybee Clinton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | KYTH | 0 | $0 | 0 | $0 | 121,883 | $920,216 |
Yearly summary of insider trading at Impinj Inc (PI) by Bybee Clinton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | PI | 0 | $0 | 0 | $0 | 3,411 | $0 |
| 2019 | PI | 0 | $0 | 0 | $0 | 4,754 | $0 |
| 2018 | PI | 0 | $0 | 0 | $0 | 2,023 | $0 |
| 2017 | PI | 4,000 | $97,720 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bellerophon Therapeutics, Inc. (BLPH) by Bybee Clinton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | BLPH | 212,666 | $2,551,992 | 0 | $0 | 0 | $0 |
Insider trading activities at 8 companies by Bybee Clinton:
1. Neumora Therapeutics, Inc. (NMRA)
2. Fate Therapeutics Inc (FATE)
3. Syros Pharmaceuticals, Inc. (SYRS)
4. Karuna Therapeutics, Inc. (KRTX)
5. Xtera Communications, Inc. (XCOM)
6. Kythera Biopharmaceuticals Inc (KYTH)
7. Impinj Inc (PI)
8. Bellerophon Therapeutics, Inc. (BLPH)
Table 1. Insider trading of Neumora Therapeutics, Inc. (NMRA) by Bybee Clinton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-09-19 | NMRA | Buy | 1,500,000 | 17.00 | 25,500,000 |
Table 2. Insider trading of Fate Therapeutics Inc (FATE) by Bybee Clinton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-10-04 | FATE | Buy | 833,333 | 6.00 | 4,999,998 |
Table 3. Insider trading of Syros Pharmaceuticals, Inc. (SYRS) by Bybee Clinton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-07-06 | SYRS | Buy | 400,000 | 12.50 | 5,000,000 |
Table 4. Insider trading of Karuna Therapeutics, Inc. (KRTX) by Bybee Clinton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-07-02 | KRTX | Buy | 200,000 | 16.00 | 3,200,000 |
Table 5. Insider trading of Xtera Communications, Inc. (XCOM) by Bybee Clinton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-11-17 | XCOM | Buy | 300,000 | 5.00 | 1,500,000 |
| 2015-11-17 | XCOM | Buy | 300,000 | 5.00 | 1,500,000 |
Table 6. Insider trading of Kythera Biopharmaceuticals Inc (KYTH) by Bybee Clinton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-10-16 | KYTH | Option Ex | 121,883 | 7.55 | 920,216 |
Table 7. Insider trading of Impinj Inc (PI) by Bybee Clinton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-10-23 | PI | Option Ex | 3,411 | .00 | 0 |
| 2019-08-13 | PI | Option Ex | 4,754 | .00 | 0 |
| 2018-06-14 | PI | Option Ex | 2,023 | .00 | 0 |
| 2017-11-09 | PI | Buy | 4,000 | 24.43 | 97,720 |
Table 8. Insider trading of Bellerophon Therapeutics, Inc. (BLPH) by Bybee Clinton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-02-19 | BLPH | Buy | 212,666 | 12.00 | 2,551,992 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bybee Clinton
(10% Owner of Neumora Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.